Insulin Market in Iran

Hadi Hayati

doi:10.18502/jppm.v10i4.20267

Hadi Hayati Assistant Professor, Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

DOI: https://doi.org/10.18502/jppm.v10i4.20267

Keywords: Insulin Market, Import, Domestic Production

Abstract

Background: The Iranian pharmaceutical market is substantial, comprising a mix of domestically produced and imported medications. Among these, insulin plays a critical role in the treatment of diabetic patients. This study aims to examine insulin from both import and domestic production perspectives within the Iranian pharmaceutical market during the year 2023.

Methods: The research is a descriptive analytical study that investigates the insulin market using statistical data from the Food and Drug Administration of Iran.

Results: The findings indicate that a significant portion of the insulin available in Iran's pharmaceutical market is sourced through imports from European countries.

Conclusion: Given the importance of this medication for diabetes management and the current conditions in the country, it is essential for drug policies to shift towards increasing domestic production of insulin. The government should remove barriers faced by local manufacturers to enable them to meet the majority of the country's insulin needs effectively.